Genetic Mechanisms and Neurodevelopment in Schizophrenia

Schizophrenia is a highly heritable psychiatric disorder arising from complex interactions between polygenic risk and neurodevelopmental processes. Common and rare genetic variants converge on pathways regulating synaptic formation, neuronal migration, transcriptional control and chromatin remodelling during critical periods of brain maturation. Early disturbances in axon guidance, interneuron development and myelination can alter cortical circuitry and excitation–inhibition balance, predisposing to the hallmark cognitive, perceptual and social impairments. Genome-wide association studies have now identified hundreds of risk loci, while rare copy-number variants and loss-of-function mutations implicate a subset of high-impact genes. Functional models using human stem cell-derived organoids and dynamic neuroimaging have begun to bridge gene-level findings with cellular and network-level phenotypes. Elucidating these genetic mechanisms and their temporal effects on neurodevelopment offers routes to early biomarkers, stratified risk prediction and novel therapeutic interventions targeting synaptic and developmental pathways.

Research from Nature Portfolio

Recent studies have applied large-scale polygenic analyses to brain imaging data, revealing that polygenic risk scores for schizophrenia and related disorders do not necessarily translate into variations in subcortical volumes or white matter microstructure in the general population. These findings underscore the complexity of genetic influences on brain structure and suggest that risk alleles may exert their effects primarily through more subtle molecular or functional pathways during neurodevelopment rather than gross anatomical alterations.

Genetic Mechanisms and Neurodevelopment in Schizophrenia publication trend

The graph below shows the total number of articles in genetic mechanisms and neurodevelopment in schizophrenia across all publications each year (not limited to Nature Index journals).

Technical terms

Polygenic risk score (PRS): A quantitative measure of an individual’s genetic liability to a disorder, calculated by summing the effects of multiple risk variants identified through GWAS.

Genome-wide association study (GWAS): A hypothesis-free approach scanning the genome for common variants associated with a trait or disorder across large populations.

Induced pluripotent stem cell-derived organoids (hCSs): Three-dimensional cellular models generated from reprogrammed human stem cells that recapitulate aspects of early cortical development.

Axon guidance: The process by which growing neuronal axons are directed towards their synaptic targets by molecular cues, critical for proper circuit formation.

Functional neuroimaging trajectory: The temporal sequence of brain activity patterns or connectivity changes associated with disease progression or development stages.

References

1. Progressive trajectories of schizophrenia across symptoms, genes, and the brain. BMC Medicine (2023).
2. Longitudinal Transcriptomic Analysis of Human Cortical Spheroids Identifies Axonal Dysregulation in the Prenatal Brain as a Mediator of Genetic Risk for Schizophrenia. Biological Psychiatry (2023).
3. Genetic architecture of schizophrenia: a review of major advancements. Psychological Medicine (2021).
4. Association of polygenic risk for major psychiatric illness with subcortical volumes and white matter integrity in UK Biobank. Scientific Reports (2017).